Cutler Group LP Collegium Pharmaceutical, Inc Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$13.58 - $18.72 $20,370 - $28,080	-1,500 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$14.78 - $19.68 $2,956 - $3,936	-200 Reduced 11.76%	1,500 $25,000
Q3 2018 Nov 07, 2018	SELL	$14.16 - $24.3 $1,416 - $2,430	-100 Reduced 5.56%	1,700 $25,000
Q2 2018 Aug 10, 2018	SELL	$21.79 - $28.29 $104,592 - $135,792	-4,800 Reduced 72.73%	1,800 $42,000
Q1 2018 May 11, 2018	BUY	$18.15 - $29.21 $36,300 - $58,420	2,000 Added 43.48%	6,600 $168,000
Q4 2017 Jan 17, 2018	BUY	$9.3 - $19.14 $39,990 - $82,302	4,300 Added 1433.33%	4,600 $84,000
Q3 2017 Oct 17, 2017	BUY	$9.15 - $11.97 $2,745 - $3,591	300	300 $3,000

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.